Clinical trials: Atheromatosis
Type2diabetes
Correlation of Xanthelasma With Atherosclerosis, Hepatic Fat and Fibrosis
Patients with diabetes with clinical feature of Xanthelasma will show increased Atherosclerosis. Objectives: Primary 1. To correlate xanthelasma and its severity to pulse wave velocity and atherosclerosis as see in carotid…
- Trial name
- NCT05945030
- Testing
- Clinical Examination
- Where
- India
- Volunteers
- 150 people, healthy volunteers welcome
- Sponsor
- Diabetes Foundation, India
Ischemic Heart Disease, Atherosclerosis
Micro-RNA Profile in Patients With Different Stages of Atherosclerosis According to CTA
The main purpose of this single-center study is to determine the spectrum and levels of cardiospecific circulating microRNAs in patients with different stages of atherosclerosis according to 640-slice multispiral computed…
- Trial name
- CT-CA-miRNA (NCT03855891)
- Testing
- blood test
- Where
- Russia
- Volunteers
- 81 people
- Sponsor
- I.M. Sechenov First Moscow State Medical University
Brachial Access, Access Complication
Evaluation of Shoulder Access Safety Using the NewMan Compression Device
The aim of the study is to evaluate the effectiveness of the NewMan compression device in shoulder access in patients with occlusive lesions of the femoral-popliteal segment of the lower extremity arteries by comparing the…
- Conditions
- Brachial Access, Access Complication, Hemostasis Compression Device, Atherosclerosis of the Arteries of the Lower Extremities
- Trial name
- SAND (NCT07714824)
- Testing
- Hemostasis is performed using a pressure bandage, Hemostasis is performed using the NewMan compression device
- Where
- Russia
- Volunteers
- 229 people
- Sponsor
- Pirogov Russian National Research Medical University
Lipidemia, Coronary Artery Disease
A CCTA Imaging Trial to Evaluate the Effect of Obicetrapib/Ezetimibe on Coronary Plaque
This placebo-controlled, double-blind, randomized, Phase 3 study is being conducted in adult participants with high-risk atherosclerotic cardiovascular disease (ASCVD) who are not adequately controlled by their maximally…
- Conditions
- Lipidemia, Coronary Artery Disease, Plaque, Atherosclerotic
- Trial name
- REMBRANDT (NCT06305559)
- Testing
- obicetrapib 10 mg + ezetimibe 10 mg FDC daily
- Where
- United States
- Volunteers
- 300 people
- Sponsor
- NewAmsterdam Pharma
Peripheral Arterial Disease, Diabetes Mellitus
Self-Managed Walking Improves Function
We are conducting a clinical research trial to determine the role of self-managed walking therapy to improve walking ability in patients with diabetes mellitus and peripheral arterial disease (PAD).
- Trial name
- NCT00611988
- Testing
- Self-managed walking, Control group
- Where
- United States
- Volunteers
- 145 people
- Sponsor
- University of Kansas
Peripheral Artery Disease, Intermittent Claudication
Walking Training in Peripheral Artery Disease (GrEnADa Sub-study)
Whereas the efficacy of exercise interventions has been abundantly proven in male with peripheral artery disease (PAD), it remains to be determined whether these interventions are effective in women.
- Trial name
- GrEnADa (NCT02879019)
- Testing
- Stretching exercise group, Walking training group
- Sponsor
- KU Leuven
Diabetic Foot Ulcer
Evaluating the Efficacy of Perinatal Membrane Allografts in Addition to the Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers.
The goal of this clinical trial is to learn if using perinatal tissue allografts improves healing of chronic, non-healing foot ulcers in diabetic patients.
- Trial name
- NCT06437028
- Testing
- Dual-layer perinatal tissue allograft, Three-layer fenestrated perinatal tissue allograft, Standard of care
- Where
- United States
- Volunteers
- 170 people
- Sponsor
- Samaritan Biologics
Atherosclerosis
Correlation Between Circulating Resistin and Vascular Inflammation Measured by 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) (18FDG-PET)
Vascular inflammation is a key factor in both the pathogenesis and outcome of atherosclerosis.Resistin was shown to induce vascular endothelial dysfunction and vascular smooth muscle cell proliferation.
- Trial name
- NCT01150019
- Testing
- Cross sectional study
- Where
- South Korea
- Volunteers
- 120 people, healthy volunteers welcome
- Sponsor
- Korea University
Atherosclerosis, Cardiovascular Diseases
Gene-Specific Responses to Exercise in Discordant Twins
To test whether specific genes affect lipoprotein and weight responses to vigorous exercise in identical twins.
- Conditions
- Atherosclerosis, Cardiovascular Diseases, Heart Diseases
- Trial name
- NCT00083837
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
Anesthesia, Peripheral Arterial Diseases
The Effect of Blood Pressure on Cerebral Perfusion During Vascular Surgery
Anesthesia reduces blood pressure and cerebral blood flow is normally considered to be maintained despite marked changes in blood pressure.
- Trial name
- NCT02531139
- Testing
- MAP maintained at 80 mmHg, MAP maintained at 60 mmHg
- Where
- Denmark
- Sponsor
- Copenhagen University Hospital, Rigshospitalet
Ischemic Heart Disease, Coronary Atherosclerosis
The SOURT OUT IV TRIAL
In a randomized study the Xience V coroary artery stent may be non inferior to the Cypher Select+ coronary stents in the treatment of unselected patients with coronary artery disease.
- Conditions
- Ischemic Heart Disease, Coronary Atherosclerosis, Percutaneous Coronary Intervention
- Trial name
- SORT OUT IV (NCT00552877)
- Testing
- Percutaneous coronary intervention (Xience V stent)
- Where
- Denmark
- Volunteers
- 2,678 people
- Sponsor
- Odense University Hospital
Cardiovascular Diseases (CVD), Drug Effect
Randomized Comparison of Morning Versus Bedtime Administration of Statins: A Cardiovascular Circadian Chronotherapy (C3) Trial
Statins inhibit hydroxy-methylglutaryl coenzyme A (HMG-CoA) reductase which catalyzes the rate-limiting step in cholesterol synthesis.
- Conditions
- Cardiovascular Diseases (CVD), Drug Effect, Atherosclerosis Cardiovascular Disease
- Trial name
- STATIN-C3 (NCT06856772)
- Testing
- Statin in the evening (such as Simvastatin, Atorvastatin, Rosuvastatin, Pravastatin), Statin in the morning (such as Simvastatin, Atorvastatin, Rosuvastatin, Pravastatin)
- Where
- Denmark
- Volunteers
- 42,000 people
- Sponsor
- Tor Biering-Sørensen
Subclinical Atherosclerotic Cardiovascular Disease, Blood Pressure
Extracellular RNAs in Relation to Cardiometabolic Risk
Background: Extracellular RNAs (exRNAs) send genetic data from cell to cell. This is how they affect the way cells communicate with each other. There are many types of exRNA, and they each serve different roles.
- Conditions
- Subclinical Atherosclerotic Cardiovascular Disease, Blood Pressure, Obesity
- Trial name
- NCT03225196
- Where
- United States
- Volunteers
- 4,495 people
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
Cardiovascular Risk Factor, Cardiovascular Diseases
VOPITB a New Devices to Determine Peripheral Arterial Stiffness: Validation Study
Our group has developed a device called "Velocidad Onda de Pulso Indice Tobillo Brazo (VOPITB)" . In this device the oscillometric method is used for easily and accurately measure the pulse wave velocity PWV in the arms and legs…
- Conditions
- Cardiovascular Risk Factor, Cardiovascular Diseases, Atherosclerosis of Artery
- Trial name
- NCT04303546
- Testing
- arterial stiffness measurements
- Volunteers
- 120 people, healthy volunteers welcome
- Sponsor
- University of Extremadura
Peripheral Arterial Disease, Leg Ulcer
Cell Therapy for Lower Limb Ulcers in Patients With Critical Limb Ischemia
Peripheral arterial disease (PAD) can progress to critical limb ischemia (CLI) of the affected lower limb, characterized by pain at rest, ulcerations or gangrene, with a high risk of amputation.
- Trial name
- NCT06326203
- Testing
- CELULAS TRONCO, CONVENTIONAL DRESSING
- Volunteers
- 40 people
- Sponsor
- UPECLIN HC FM Botucatu Unesp
Peripheral Arterial Occlusive Disease Fontaine Stage IIa
Acute Local Metabolomic Alterations in Blood and Muscle Tissue in Intermittent Claudication
The most common clinical presentation of lower extremity arterial disease is intermittent claudication. Current understanding of the pathophysiology of intermittent claudication, as well as its treatment options are limited.
- Trial name
- NCT05111379
- Where
- Estonia
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- University of Tartu
Angina Pectoris, Atherosclerosis
Danish Study of Non-Invasive Diagnostic Testing in Coronary Artery Disease 3
In a cohort of symptomatic patients referred to coronary computed tomography angiography (CCTA), the investigators aim is: 1. To investigate and compare the diagnostic precision of Rubidium Positron Emission Tomography (Rb PET)…
- Conditions
- Angina Pectoris, Atherosclerosis, Coronary Artery Disease, Myocardial Ischemia
- Trial name
- Dan-NICAD 3 (NCT04707859)
- Testing
- Head to head comparison: Rubidium vs 15O-water PET
- Where
- Denmark
- Volunteers
- 1,000 people
- Sponsor
- University of Aarhus
Peripheral Arterial Disease, Intermittent Claudication
Moderate Intensity Functional Training as Adjuvant Treatment in Patients With Peripheral Arterial Disease
Traditional aerobic training and muscle resistance ('strength') training have been shown to be effective for improving functional and health-related quality of life (HRQoL) outcomes in peripheral arterial disease (PAD).
- Trial name
- NCT05126680
- Testing
- Supervised exercise therapy: intermittent treadmill walking exercise and moderate intensity functional training, Supervised exercise therapy: intermittent treadmill walking exercise
- Where
- Spain
- Volunteers
- 15 people
- Sponsor
- European University Miguel de Cervantes
Type 2 Diabetes, Peripheral Arterial Disease
Liraglutide and Peripheral Artery Disease
STARDUST is an open-label, two-arm randomized controlled trial, aimed at evaluating the effects of liraglutide on peripheral perfusion, as compared with the aggressive treatment of cardio-metabolic risk factors, in people with…
- Trial name
- STARDUST (NCT04881110)
- Testing
- Liraglutide, Control
- Where
- Italy
- Volunteers
- 60 people
- Sponsor
- University of Campania Luigi Vanvitelli
Peripheral Arterial Disease
Optimization of Treatment in Patients With Severe Peripheral Ischemia (Fontaine Stage IIb)
Evaluate the possibility of optimization of therapy with prostanoids (iloprost), in patients with Fontaine's stage IIb severe chronic ischemia, both in patients eligible for surgery both in patients for which it is only possible…
- Trial name
- 2bPILOT (NCT01718288)
- Testing
- iloprost, Standard Treatment (aspirin.....),
- Where
- 14 sites in Italy
- Volunteers
- 150 people
- Sponsor
- Fadoi Foundation, Italy
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.